Management of fever without source in infants and children

Annals of Emergency Medicine

Volumn 36, Issue 6, 2000, Pages 602-614

  Baraff, Larry J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BLOOD CULTURE; BODY TEMPERATURE; CHILD; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION; VACCINATION;

EID: 0033663050     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2000.110820     Document Type: Article

References (121)

1. The spectrum and frequency of illness presenting to a pediatric emergency department
2. Spectrum and frequency of pediatric illness presenting to a general community hospital emergency department
3. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era
4. Characteristics and management of febrile young children seen in a university family practice
5. Antibiotic administration to treat possible occult bacteremia in febrile children
6. Antimicrobial treatment of occult bacteremia: A multicenter cooperative study
7. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia
8. Predictors of occult pneumococcal bacteremia in young febrile children
9. Practice guideline for the management of infants and children with fever without source 0-36 months of age
10. Occult bacteremia: Is there a standard of care?
11. The management of febrile infants by primary-care pediatricians in Utah: Comparison with published practice guidelines
12. Pediatricians' awareness of and attitudes about four clinical practice guidelines
13. Pediatric emergency medicine practice patterns: A comparison of pediatric and general emergency physicians
14. A survey about management of febrile children without source by primary care physicians
15. Predictors of physician compliance with a published guideline on management of febrile infants
16. Management of the young febrile child: A commentary on recent practice guidelines
17. Antibiotic therapy in febrile children: 'Best-laid schemes'
18. Observation, history and physical examination in diagnosis of illnesses in febrile children less than or equal to 24 months
19. Observation scales to identify serious illness in febrile children
20. Predictive value of abnormal physical examination findings in ill-appearing and well-appearing febrile children
21. Effect of routine emergency department pulse oximetry screening on medical management
22. A comparison of pulse oximetry and respiratory rate in patient screening
23. Pulse oximetry as a fifth pediatric vital sign
24. Supralingual temperatures compared to tympanic and rectal temperatures
25. Modern electronic and chemical thermometers used in the axilla are inaccurate
26. Reliability of infrared tympanic thermometry in the detection of rectal fever in children
27. Bacteremia in children afebrile at presentation to an emergency room
28. Evaluation of management of febrile infants younger than 60 days of age
29. Correlating reported fever in young infants with subsequent temperature pattern and rate of serious bacterial infections
30. Fever and petechiae in children
31. Incidence of bacteremia in infants and children with fever and petechiae
32. Approach to the febrile patient with no obvious focus of infection
33. Management of febrile outpatient neonates
34. Hospitalization v outpatient treatment of young, febrile infants
35. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis
36. Iatrogenic risks and financial costs of hospitalizing febrile infants
37. Outpatient treatment of febrile infants 28 to 90 days of age with intramuscular administration of ceftriazone
38. Outpatient management without antibiotics of fever in selected infants
39. The efficacy of routine outpatient management without antibiotics of fever in selected infants
40. Difficulties in universal application of criteria identifying infants at low risk for serious bacterial infection
41. Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infections
42. Febrile infants less than eight weeks old: Predictors of infection
43. Febrile infants at low risk for serious bacterial infection - An appraisal of the Rochester criteria and implications for management
44. Identification of febrile neonates unlikely to have bacterial infections
45. Which febrile infants younger than two weeks of age are likely to have sepsis? A pilot study
46. Outpatient management of selected infants younger than two months of age evaluated for possible sepsis
47. Probability of bacterial infections in infants less than three months of age: A meta-analysis
48. Failure of infant observation scales in detecting serious illness in febrile 4 to 8 week old infants
49. Lumbar puncture as a factor in the pathogenesis of meningitis
50. Meningitis after lumbar puncture in children with bacteremia
51. Treatment of occult bacteremia: A prospective randomized clinical trial
52. Bacteremia in 28 ambulatory children
53. Pneumococcal bacteremia in pediatric patients
54. Bacteremia in an ambulatory setting. Improved outcome in children treated with antibiotics
55. Risk factors for the development of bacterial meningitis among children with occult bacteremia
56. Comparison of the BacT/Alert pediatric blood culture system, Pedi-BacT, with conventional culture using the 20-milliliter Becton-Dickinson supplemented peptone broth tube
57. Detection of bacteremia by Difco ESP blood culture system
58. Comparison of the BacT/Alert FAN aerobic and the Difco ESP 80A aerobic bottles for pediatric blood cultures
59. Evaluation of false positive blood cultures: Guidelines for early detection of contaminated cultures in febrile children
60. Long term neurological outcome of herpes encephalitis
61. Vidarabine versus acyclovir therapy in herpes simplex encephalitis
62. Enerovirus infections: Diagnosis and treatment
63. Perinatal echovirus infection: Insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries
64. Is a chest radiograph necessary in the evaluation of every febrile infant less than 8 weeks of age?
65. Indications for chest roentgenogram in the febrile young infant
66. Prevalence of urinary tract infection in febrile young children in the emergency department
67. Prevalence of urinary tract infection in febrile infants
68. Prevalence of bacteriuria in febrile children
69. Practice parameter: The diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children
70. Urinary tract infections in young febrile infants
71. Oral versus initial intravenous therapy for urinary tract infections in young febrile children
72. Enhanced urinalysis as a screening test for urinary tract infection
73. Is urine culture necessary to rule out urinary tract infection in young febrile children?
74. Screening tests for urinary tract infection: A meta-analysis
75. Urinary tract infections in febrile infants less than 8 weeks of age
76. The value of urinalysis in differentiating acute pyelonephritis from lower urinary tract infection in febrile infants
77. Nonbacterial pneumonia
78. Pneumonia in pediatric outpatients: Cause and clinical manifestations
79. Differentiating bacterial from viral pneumonias in children
80. Radiographic findings and etiologic diagnosis in ambulatory childhood pneumonias
81. Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department
82. Occult pneumonias: Empiric chest radiographs in febrile children with leukocytosis
83. Clinical predictors of pneumonia as a guide to ordering chest roentgenograms
84. Correlation of pulmonary signs and symptoms with chest radiographs in the pediatric age group
85. Decision rules and clinical prediction of pneumonia: Evaluation of low-yield criteria
86. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
87. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of the northern California Kaiser Permanente efficacy trial
88. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1995
89. Is Haemophilus influenzae finished?
90. Risk factors for invasive pneumococcal disease in children: A population-based case-control study in North America
91. Bacterial meningitis and septicemia in sickle cell disease
92. Invasive pneumococcal infections in human immunodeficiency virus-infected children
93. Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use
94. Long-term sequelae of pneumococcal meningitis in children
95. Outcomes of bacterial meningitis in children: A meta-analysis
96. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis
97. Parenteral vs oral antibiotics in the prevention of serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: A meta-analysis
98. Blood cultures in private pediatric practice: An eleven-year experience
99. Outcome of unsuspected pneumococcemia in children not initially admitted to the hospital
100. A comparative study of the prevalence, outcome and prediction of bacteremia in children
101. Effect of antiobiotic therapy on the outcome of outpatients with unsuspected bacteremia
102. Bacteremia in children: An outpatient clinical review
103. Relationship of bacteremia to antipyretic therapy in febrile children
104. Unsuspected meningococcemia
105. Neisseria meningitidis bacteremia in children: Quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy
106. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease
107. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
108. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysacchadde vaccine, and antibiotic prophylaxis
109. Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae
110. Carriage of pneumococci after pneumococcal vaccination
111. Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to infants in Soweto, South Africa
112. Effect of a 9-valent pneumococcal vaccine conjugated to CRM197 (PncCRM9) on nasopharyngeal (NP) carriage of vaccine type and non-vaccine type S pneumoniae (Phc) strains among day-care-center (DCC) attendees
113. Occult bacteremia in young febrile children
114. Management of the young febrile child. Clinical guidelines in the setting of incomplete evidence
115. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia
116. Three-year multicenter surveillance of systemic pneumococcal infections in children
117. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: Current antibiotic therapy in the 1990s
118. Therapy for children with invasive pneumococcal infections
119. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics
120. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis